A call to dismantle structural heteronormative care
“That is a very heteronormative lens.” These words were uttered to me by a 23-year-old female patient as I explained i-PLEDGE and the steps she must complete to take oral isotretinoin. The visit started as fairly routine. A young female presented with a complaint of acne. I quickly appraised the patient on entering. She wasRead more …A call to dismantle structural heteronormative care originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - May 29, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/naila-russell" rel="tag" data-wpel-link="internal" > Naila Russell, DNP, FNP-BC < /a > < /span > Tags: Policy Dermatology Primary Care Source Type: blogs
Adult acne: Understanding underlying causes and banishing breakouts
“I’m not a teenager anymore, why do I still have acne?!” This is a question we hear from patients on a daily basis. The truth is, it is quite common to see acne persist into adulthood. Although acne is commonly thought of as a problem of adolescence, it can occur in people of all ages.
Adult acne has many similarities to adolescent acne with regard to both causes and treatments. But there are some unique qualities to adult acne as well.
What causes adult acne?
Adult acne, or post-adolescent acne, is acne that occurs after age 25. For the most part, the same factors that cause acne in adolescents are at play in adult ...
Source: Harvard Health Blog - September 21, 2019 Category: Consumer Health News Authors: Kristina Liu, MD, MHS Tags: Health Skin and Hair Care Source Type: blogs
How to treat dry eyes
How common are dye eyes?The prevalence of dry eyes has been estimated to be 5-30% percent in persons aged 50 years and older, 7% of US adult population has been diagnosed with dry eye disease. The prevalence increases with age (2.7% in those 18 to 34 years old vs. 19% in those aged 75 years and older). Prevalence is higher in women than men (9% versus 4%).What are the risk factors for dry eye disease?- Advanced age- Female gender- Hormonal changes (primarily due to decreased androgens)- Systemic diseases (eg, diabetes mellitus, Parkinson disease)- Contact lens wear- Systemic medications (antihistamines, anticholinergi...
Source: Clinical Cases and Images - Blog - January 2, 2018 Category: Universities & Medical Training Authors: noreply at blogger.com (Ves Dimov) Tags: Ophthalmology Source Type: blogs
FDA Public Meeting on Training Health Care Providers on Pain Management and Safe Use of Opioid Analgesics
In 2012, FDA instituted a risk evaluation and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioids that required companies marketing ER/LA opioids to provide a medication guide and make training available to prescribers.
Under the REMS, the training must be provided by accredited providers and cover all elements of the agency's Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics. However, while the agency set goals for prescriber participation, prescribers were not required under the REMS to go through with the training.
On May 9th and 10th, 2017, the...
Source: Policy and Medicine - May 23, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Welcome to McMedicine, may I please take your order?
A.J. Smith, a pseudonym of course, walked into my office today, unhappily. Most of her topical medications for acne caused too much irritation. The ones that didn’t, weren’t working. The doxycycline caused photosensitivity in the past. But her friend’s dermatologist gave her isotretinoin, better known as Accutane, and she completely cleared. As such, that’s what my patient demanded. There was only one problem. The degree of her acne didn’t warrant such an aggressive approach. I explained the risks at length with her, and I explained politely why she wasn’t a candidate. This fell on deaf ears....
Source: Kevin, M.D. - Medical Weblog - August 22, 2016 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/anonymous" rel="tag" > Anonymous < /a > Tags: Physician Primary care Source Type: blogs
Fwd: Secondary causes of pseudotumor cerebri syndrome
From: Djacobs272@aol.comTo: dhj1.neurology@blogger.comSent: 5/13/2014 2:29:28 P.M. Eastern Daylight TimeSubj: Secondary causes of pseudotumore cerebri syndrome (from Neurology, 2013; 81:1159-1165 cerebrovenous abnormalities:cerebral venous thrombosis (CVT)bilateral jugular thrombosis or surgical ligationmiddle ear or mastoid infectionincreased right heart pressuresuperior vena cava syndromeAV fistulashypercoagulable statesMedications and exposures:Antibiotics: tetracycline, minocycline, doxycycline, nalidixic acid, sulfa drugsVitamin A and retinoidshypervitaminosis A, isotretinoin, all trans retinoic acid...
Source: neurologyminutiae - May 14, 2014 Category: Neurologists Source Type: blogs
FDA To Study Prescription Drug Advertising Aimed At Teenagers
Teenagers are, by and large, a vulnerable group that is also exposed regularly to prescription drug advertising. But how do they perceive the messages for medicines, especially those that treat afflictions common to that time of life? And to what extent are they able to sift through the information and assess the risks and benefits?
In hopes of assessing teenage reactions to such situations, the FDA plans to run a randomized, controlled study by showing Internet- based promotional campaigns for fake medicines for acne and attention deficit hyperactivity disorder in order to compare their perceptions of the messages with yo...
Source: Pharmalot - November 4, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
"It may have been Roaccutane"
Open verdict in death of Cheltenham College pupilJack Bowlby, the nephew of former champion racehorse trainer and novelist Jenny Pitman, was prescribed Roaccutane in December 2011. Photograph: SWNS.comA coroner has expressed concern at the way a prestigious public school cares for pupils in crisis following the case of a boy who died after taking an acne drug that has been blamed for causingdepression.The parents of 16-year-old Jack Bowlby, who was found with a ligature around his neck, also criticised Cheltenham College for the way it acted after the teenager expressed "very dark thoughts".Jack, the nephew of former champ...
Source: PharmaGossip - July 7, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
DOJ Probing International Pharmaceutical Manufacturing
Earlier this year, we noted that a new enforcement focus for the U.S. Department of Justice (DOJ) will be increased oversight to ensure compliance with the Food and Drug Administration's (FDA) current good manufacturing practices (cGMPs) regulations. Specifically, Maame Ewusi-Mensah Frimpong, Deputy Assistant Attorney General (DAAG) for DOJ's Consumer Protection Branch (CPB), noted her division has long worked closely with FDA to promote the safety of pharmaceutical products.
Several months later, it appears that DOJ is acting on this promise in two recent cases. As reported by the Washington Post, Reuters, and ...
Source: Policy and Medicine - July 5, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
HHS OIG Report: FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies (REMS) Improve Drug Safety
The Office of the Inspector General (OIG) for the Department of Health and Human Services (HHS) released a report, which asserts that the Food and Drug Administration (FDA) is not receiving crucial information from pharmaceutical manufactures regarding Risk Evaluation and Mitigation Strategies (REMS). OIG also released a podcast explaining the report.
The Federal Food, Drug, and Cosmetic Act (FDCA), as amended by the Food and Drug Administration Amendments Act of 2007 and the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA), authorizes FDA to require REMS for certain drugs and biological product...
Source: Policy and Medicine - February 25, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
FutureDerm Time-Release Retinol 0.5 Gel Treatment- a Science Based Solution for Rough Skin
Today’s post is sponsored by FutureDerm.
If you’re not familiar with FutureDerm.com you should be. It’s another website that embraces a science-based approached to beauty (much like The Beauty Brains.) Nicki Zevola, the owner of the site, is an aspiring dermatologist who has formulated her own line of products. She recently asked to us to write a review of her FutureDerm Time-Release Retinol 0.5 Gel Treatment.
What does it claim?
Contains 0.5% concentrated retinol
Fast absorbing (absorbs in a second compared to most retinoid creams which are thick and take up to 30 minutes)
Sustained release technology k...
Source: thebeautybrains.com - January 17, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
